Review: could Strattera cause Akathisia?


Summary

Akathisia is found among people who take Strattera, especially for people who are male, 50-59 old , have been taking the drug for < 1 month, also take medication Lexapro, and have Attention deficit/hyperactivity disorder . We study 19,171 people who have side effects while taking Strattera from FDA and social media. Among them, 22 have Akathisia. Find out below who they are, when they have Akathisia and more.

You are not alone

Join a support group for people who take Strattera and have Akathisia >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Strattera

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Strattera 19,782 users)

Akathisia

Akathisia (a movement disorder characterized by a feeling of inner restlessness) has been reported by people with suicidal ideation, confusional state, insomnia, paranoia, high blood pressure (latest reports from 6,447 Akathisia patients).

On Aug, 29, 2016

19,171 people reported to have side effects when taking Strattera.
Among them, 22 people (0.11%) have Akathisia


Number of reports submitted per year:

Could Strattera cause Akathisia?

Time on Strattera when people have Akathisia *:

  • < 1 month: 50.0 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 16.67 %
  • 2 - 5 years: 16.67 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Akathisia when taking Strattera *:

  • female: 40.91 %
  • male: 59.09 %

Age of people who have Akathisia when taking Strattera *:

  • 0-1: 0.0 %
  • 2-9: 23.53 %
  • 10-19: 23.53 %
  • 20-29: 5.88 %
  • 30-39: 17.65 %
  • 40-49: 5.88 %
  • 50-59: 23.53 %
  • 60+: 0.0 %

Severity if Akathisia when taking Strattera **:

  • least: 0.0 %
  • moderate: 100 %
  • severe: 0.0 %
  • most severe: 0.0 %

Top conditions involved for these people *:

  • Attention Deficit/hyperactivity Disorder (7 people)
  • Depression (3 people)
  • Sleep Disorder (2 people)
  • Endometriosis (2 people)
  • Anxiety (2 people)

Top co-used drugs for these people *:

  • Lexapro (8 people)
  • Zyprexa (5 people)
  • Metoclopramide (4 people)
  • Cymbalta (4 people)
  • Yasmin (3 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Akathisia when taking Strattera?

Browse all side effects of Strattera

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Akathisia

Akathisia

Could your condition cause Akathisia

Akathisia

You may be interested in these reviews

More reviews for: Strattera, Akathisia


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.